General Information
Version
5.2
Revision date
2025-04-14
Product name
Ceftolozane / Tazobactam Injection Formulation
1.2.1 Relevant identified uses
Pharmaceutical
supplier name
MSD
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334, H373
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
GHS Classification GHS Classification Respiratory sensitization Category 1 Specific target organ toxicity Category 2 (Kidney, Liver) repeated exposure
Signal word
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breathing diffi- culties if inhaled. H373 May cause damage to organs (Kidney, Liver) through prolonged or repeated exposure.
Prevention
P260 Do not breathe dust. P284 Wear respiratory protection.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/ physician.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means
2.1 Classification of the substance or mixture
Respiratory sensitization : Category 1 Specific target organ toxicity : Category 2 (Kidney, Liver) - repeated exposure
